BH Labs Knowledge Center

A 2024 clinical study found no significant difference in swelling reduction or patient experience between manual lymphatic drainage (MLD) and intermittent pneumatic compression therapy (IPCT) in patients with lower limb lymphedema. The findings support mechanical systems like those from BH Labs as a convenient, scalable, and clinically effective alternative to hands-on therapy in lymphedema management.

A 2021 clinical trial found that HBOT significantly improved skin quality in older adults, increasing collagen density (p < 0.001), elastic fiber length (p < 0.0001), and blood vessel formation. It also reduced senescent cell counts, suggesting HBOT may reverse skin aging at a cellular level—offering clinics a science-backed, noninvasive approach to aesthetic and regenerative care.